Your browser doesn't support javascript.
loading
Real-world evidence and product development: Opportunities, challenges and risk mitigation.
Naidoo, Poobalan; Bouharati, Célia; Rambiritch, Virendra; Jose, Nadina; Karamchand, Sumanth; Chilton, Robert; Leisegang, Rory.
Afiliación
  • Naidoo P; Department of Nephrology, Inkosi Albert Luthuli Central Hospital, Durban, South Africa.
  • Bouharati C; Clinical Operations and Medical Affairs, Sanofi, Midrand, South Africa. celia.bouharati@gmail.com.
  • Rambiritch V; Discipline of Pharmaceutical Sciences, University of KwaZulu-Natal, Durban, South Africa.
  • Jose N; Department of Health Informatics, Rutgers School of Health Professions, The State University of New Jersey, Newark, New Jersey, United States.
  • Karamchand S; Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
  • Chilton R; Faculty of Medicine, Division of Cardiology and Interventional Cardiology, University of Texas Health Science Centre at San Antonio, San Antonio, Texas, United States.
  • Leisegang R; Faculty of Pharmacy, Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.
Wien Klin Wochenschr ; 133(15-16): 840-846, 2021 Aug.
Article en En | MEDLINE | ID: mdl-33837463

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Wien Klin Wochenschr Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Wien Klin Wochenschr Año: 2021 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Austria